Parcourir par sujet "papillomavirus infection"

Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening

Chatzistamatiou K., Vrekoussis T., Tsertanidou A., Moysiadis T., Mouchtaropoulou E., Pasentsis K., Kitsou A., Moschaki V., Ntoula M., Zempili P., Halatsi D., Truva T., Piha V., Agelena G., Daponte A., Vanakara P., Paschopoulos M., Stefos T., Lymberis V., Kontomanolis E.N., Makrigiannakis A., Deligeoroglou E., Panoskaltsis T., Adonakis G., Michail G., Stamatopoulos K., Agorastos T. (2020)

Background: Human papillomavirus (HPV)-DNA testing combined with self-sampling could increase cervical cancer screening effectiveness, utilizing a sensitive screening modality and an easy sampling method with minimal pain ...

Association of codon 72 polymorphism of p53 with the severity of cervical dysplasia, E6-T350G and HPV16 variant lineages in HPV16-infected women

Moschonas G.D., Tsakogiannis D., Lamprou K.A., Mastora E., Dimitriou T.G., Kyriakopoulou Z., Kottaridi C., Karakitsos P., Markoulatos P. (2017)

Purpose. Polymorphic variability in the tumour-suppressor protein p53 at codon 72 has a considerable impact on cervical cancer development. The present study clarified the association between p53 codon 72 genotypes and the ...

Association of p16 (CDKN2A) polymorphisms with the development of HPV16-related precancerous lesions and cervical cancer in the Greek population

Tsakogiannis D., Moschonas G.D., Bella E., Kyriakopoulou Z., Amoutzias G.D., Dimitriou T.G., Kottaridi C., Markoulatos P. (2018)

The tumor suppressor protein p16 plays a fundamental role in cell cycle regulation and exerts a protective effect against tumor growth. Two different polymorphisms at positions 540 and 580 at the 3′UTR of exon 3 of p16 ...

Awareness of human papilloma virus and cervical cancer prevention among Greek female healthcare workers

Farazi P.A., Hadji P., Roupa Z. (2017)

The incidence rate of cervical cancer varies by geographic region, with less developed regions showing the highest rates. All risk factors for cervical cancer are actually preventable if appropriate lifestyle changes are ...

Genetic variability of the HPV16 early genes and LCR. Present and future perspectives

Bletsa G., Zagouri F., Amoutzias G.D., Nikolaidis M., Zografos E., Markoulatos P., Tsakogiannis D. (2021)

Human papillomavirus 16 (HPV16) infection is the aetiologic factor for the development of cervical dysplasia and is regarded as highly carcinogen, because it is implicated in more than 50% of cervical cancer cases, worldwide. ...

Herpes viruses and human papilloma virus in nasal polyposis and controls

Ioannidis D., Lachanas V.A., Florou Z., Bizakis J.G., Petinaki E., Skoulakis C.E. (2015)

Introduction: Chronic rhinosinusitis with nasal polyps is a multifactorial disease entity with an unclear pathogenesis. Contradictory data exist in the literature on the potential implication of viral elements in adult ...

HPV infection in oropharyngeal squamous cell carcinomas: Correlation with tumor size

Gletsou E., Papadas T.A., Baliou E., Tsiambas E., Ragos V., Armata I.E., Metaxas G.E., Fotiades P.P. (2018)

Purpose: Human papillomavirus (HPV) is implicated in carcinogenesis of a variety of epithelia, including oropharyngeal and laryngeal. High risk (HR) HPV persistent infection in head and neck squamous cell carcinomas (HNSCC) ...

Human papilloma virus (HPV) and fertilization: A mini review

Zacharis K., Messini C.I., Anifandis G., Koukoulis G., Satra M., Daponte A. (2018)

Human papilloma virus (HPV) is one of the most prevalent viral sexually transmitted diseases. The ability of HPV to induce malignancy in the anogenital tract and stomato-pharyngeal cavity is well documented. Moreover, HPV ...

Identification of rearranged sequences of HPV16 DNA in precancerous and cervical cancer cases

Tsakogiannis D., Bletsa M., Kyriakopoulou Z., Dimitriou T.G., Kotsovassilis C., Panotopoulou E., Markoulatos P. (2016)

Integration of HPV16 DNA into the host chromosome is considered to be a crucial step towards genomic instability and cervical cancer development. Aim of the present study was to investigate the presence of HPV16 rearranged ...

Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network across Rural Greece: The Grecoself study

Agorastos T., Chatzistamatiou K., Tsertanidou A., Mouchtaropoulou E., Pasentsis K., Kitsou A., Moysiadis T., Moschaki V., Skenderi A., Katsiki E., Aggelidou S., Venizelos I., Ntoula M., Daponte A., Vanakara P., Garas A., Stefos T., Vrekoussis T., Lymberis V., Kontomanolis E.N., Makrigiannakis A., Manidakis G., Deligeoroglou E., Panoskaltsis T., Decavalas G.O., Michail G., Kalogiannidis I., Koukoulis G., Zempili P., Halatsi D., Truva T., Piha V., Agelena G., Chronopoulou A., Vaitsi V., Chatzaki E., Paschopoulos M., Adonakis G., Kaufmann A.M., Hadzidimitriou A., Stamatopoulos K. (2019)

Self-sampling for human papillomavirus (HPV) testing is an alternative to physician sampling particularly for cervical cancer screening nonattenders. The GRECOSELF study is a nationwide observational cross-sectional study ...

Molecular approaches for HPV genotyping and HPV-DNA physical status

Tsakogiannis D., Gartzonika C., Levidiotou-Stefanou S., Markoulatos P. (2017)

Persistent infection with high-risk human papillomavirus (HPV) genotypes is the leading cause of cervical cancer development. To this end several studies have focused on designing molecular assays for HPV genotyping, which ...

Polymorphic variability in the exon 19 of the RB1 gene and its flanking intronic sequences in HPV16-associated precancerous lesions in the Greek population

Tsakogiannis D., Moschonas G.D., Daskou M., Stylianidou Z., Kyriakopoulou Z., Kottaridi C., Dimitriou T.G., Gartzonika C., Markoulatos P. (2018)

Purpose. The tumour suppressor protein RB plays a decisive role in negative control of the cell cycle, inhibiting tumour development. The present analysis investigated the prevalence of the nucleotide polymorphism A153104G, ...

Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): A systematic review

Skoulakis A., Fountas S., Mantzana-Peteinelli M., Pantelidi K., Petinaki E. (2019)

Background: Human Papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection. The present systematic review summarizes data regarding the prevalence of HPV and the distribution of ...

Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology

Agorastos, T.; Chatzistamatiou, K.; Katsamagkas, T.; Koliopoulos, G.; Daponte, A.; Constantinidis, T.; Constantinidis, T. C. (2015)

Objectives The objective of the present study is to assess the performance of a high-risk human papillomavirus (HR-HPV) DNA test with individual HPV-16/HPV-18 genotyping as a method for primary cervical cancer screening ...

Vaccination against human papillomavirus among 865 female students from the health professions in central Greece: A questionnaire-based cross-sectional study

Papagiannis, D.; Rachiotis, G.; Symvoulakis, E. K.; Daponte, A.; Grivea, I. N.; Syrogiannopoulos, G. A.; Hadjichristodoulou, C. (2013)

Background: There are still sparse data on vaccination coverage against human papillomavirus (HPV) among students in the health professions. The aim of this study was to investigate HPV vaccination coverage in female ...

WarmStart colorimetric LAMP for the specific and rapid detection of HPV16 and HPV18 DNA

Daskou M., Tsakogiannis D., Dimitriou T.G., Amoutzias G.D., Mossialos D., Kottaridi C., Gartzonika C., Markoulatos P. (2019)

Background and objectives: Persistent infection with High-Risk HPV genotypes is the principal cause for the development of cervical cancer with HPV16 and HPV18 to be the most frequently identified HPV genotypes observed ...

Α 2-stage, nested-like nucleic acid amplification method (IsoPCR)for the highly sensitive detection of HPV16 and HPV18 DNA

Daskou M., Tsakogiannis D., Dimitriou T.G., Manali M., Apti C., Amoutzias G.D., Mossialos D., Kottaridi C., Markoulatos P. (2019)

Molecular detection of HPV DNA is considered as the gold standard for the diagnosis of cervical disease. Although the molecular assays for the identification of HPV16 and HPV18 have helped identify cervical cancer incidents, ...